Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The normal human prostate does not significantly affect blood DHT levels.

New compounds may soon be tested to treat excessive hair growth in women.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Hair loss in postmenopausal woman caused by ovarian issue.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

OCT binds strongly to hair sheath cells and may affect skin and hair growth with fewer side effects than vitamin D3.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Hair loss has many causes and treatments, and losing some hair daily is normal; proper diagnosis is key, and minoxidil can help treat it.